Filter
269
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
15
New Publications
65
Language
Document type
No document type
112
Studies & Reports
72
Guidelines
42
Manuals
23
Strategic & Response Plan
14
Fact sheets
4
Situation Updates
2
Countries / Regions
Kenya
24
Nigeria
9
South Africa
9
Liberia
7
Ghana
7
Uganda
7
Zimbabwe
7
India
7
Ethiopia
6
Sierra Leone
5
Tanzania
5
Bangladesh
5
Western and Central Europe
5
Philippines
4
Zambia
4
Malawi
4
Botswana
4
Global
4
Senegal
3
Nepal
3
Syria
3
Rwanda
3
Ukraine
3
Eastern Europe and Central Asia
3
Cambodia
2
Indonesia
2
Benin
2
Namibia
2
Eswatini/ Swaziland
2
Myanmar / Burma
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Cameroon
1
Haiti
1
Thailand
1
Sudan
1
Brazil
1
Lesotho
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Asia
1
Africa
1
Eastern Europe
1
Moldova
1
North America
1
Gabon
1
Authors & Publishers
Publication Years
Category
Countries
140
Clinical Guidelines
16
Pharmacy & Technologies
11
Public Health
10
Key Resources
6
Women & Child Health
5
Capacity Building
1
Toolboxes
Pharmacy
49
AMR
48
COVID-19
19
Mental Health
8
TB
7
HIV
5
Ebola
3
Conflict
3
Caregiver
3
NTDs
3
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
Rapid Response
1
Refugee
1
Health Financing Toolbox
1
NCDs
1
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
Assessment Report
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k
...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a
...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
For the Fiscal Year 2014-2015, the Health Sector continued to implement interventions and strategies meant to improve the availability, accessibility and utilization of quality healthcare services across public and private health facilities; and to ensure the reduction of the burden of communicable
...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the
...
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic
...
Global actions to reduce antimicrobial resistance (AMR) include optimising the use of antimicrobial medicines in human and animal health. In countries with weak healthcare regulation, this requires a greater understanding of the drivers of antibiotic use from the perspective of providers and consume
...
Technology landscape
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr
...
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficulties and ensure sustainability.
EMCDDA Insights - 11
Accessed: 14.03.2019
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-
...
